Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease

International Journal of Antimicrobial Agents

Volumn 31, Issue SUPPL. 1, 2008, Pages 96-101

  Ha, U Syn ^a   Kim, Min Eui ^b   Kim, Chul Sung ^c   Shim, Bong Suk ^d   Han, Chang Hee ^a   Lee, Sang Don ^e   Cho, Yong Hyun ^a  

^a The Catholic University of Korea   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Chosun University   (South Korea)

^d Ewha Womans University School of Medicine   (South Korea)

^e Pusan National University School of Medicine   (South Korea)

Author keywords

Acute bacterial prostatitis; Microbiology; Susceptibility

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; OFLOXACIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TOBRAMYCIN;

ACUTE DISEASE; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CANDIDA; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE COURSE; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEISSERIA GONORRHOEAE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATITIS; PSEUDOMONAS; SALMONELLA; SERRATIA MARCESCENS; SOUTH KOREA; STREPTOCOCCUS AGALACTIAE; SYMPTOM; URINALYSIS;

ADULT; AGED; AMIKACIN; ANTI-BACTERIAL AGENTS; BACTERIA; CEPHALOSPORINS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; HUMANS; KOREA; MALE; MIDDLE AGED; PROSTATITIS; RETROSPECTIVE STUDIES;

EID: 38349056407     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.07.041     Document Type: Article

References (10)

1. Krieger J.N., Nyberg Jr. L., and Nickel J.C. NIH consensus definition and classification of prostatitis. JAMA 282 (1999) 236-237
2. Hua V.N., and Schaeffer A.J. Acute and chronic prostatitis. Med Clin North Am 88 (2004) 483-494
3. Meares Jr. E.M. Prostatitis. Med Clin North Am 75 (1991) 405-424
4. Schaeffer A.J. Diagnosis and treatment of prostatic infections. Urology 36 5 Suppl. (1990) 13-17
5. Stamey T.A. Pathogenesis and treatment of urinary tract infections (1980), Williams & Wilkins, Baltimore, MD p. 343-429
6. López-Plaza I., and Bostwick D.G. Prostatitis. In: Bostwick D.G. (Ed). Pathology of the prostate (1990), Churchill Livingstone, New York p. 15-30
7. Dowling K.J., Roberts J.A., and Kaack M.B. P-fimbriated Escherichia coli urinary tract infection: a clinical correlation. South Med J 80 (1987) 1533-1536
8. Kim ME, Ha US, Cho YH. The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006. Int J Antimicrob Agents [in this Supplement] 2008:p. 15-18.
9. Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., and Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 29 (1999) 745-758
10. Naber KG, Bishop MC, Bjerklund-johansen TE, Botto H, Cek M, Grabe B, et al. The management of urinary and male genital tract infections. In: EAU guideline office, editor. European Association of Urology Guidelines. Arnhem, The Netherlands: Drukkerij Gelderland; 2006. p. 1-126.